Compare ABM & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABM | INSP |
|---|---|---|
| Founded | 1909 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | N/A | 2018 |
| Metric | ABM | INSP |
|---|---|---|
| Price | $45.58 | $78.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $51.50 | ★ $127.40 |
| AVG Volume (30 Days) | 695.0K | ★ 1.2M |
| Earning Date | 03-11-2026 | 02-11-2026 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | ★ 102.34 | 34.77 |
| EPS | ★ 2.59 | 1.48 |
| Revenue | ★ $8,745,900,000.00 | $882,622,000.00 |
| Revenue This Year | $5.71 | $15.30 |
| Revenue Next Year | $1.99 | $10.84 |
| P/E Ratio | ★ $17.29 | $55.56 |
| Revenue Growth | 4.62 | ★ 16.81 |
| 52 Week Low | $40.00 | $70.77 |
| 52 Week High | $54.90 | $203.12 |
| Indicator | ABM | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 56.51 | 32.59 |
| Support Level | $44.59 | $77.75 |
| Resistance Level | $46.60 | $84.24 |
| Average True Range (ATR) | 0.93 | 5.52 |
| MACD | 0.06 | -1.02 |
| Stochastic Oscillator | 64.69 | 6.12 |
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.